Kharash daawaynta kansarka sambabada unugyada cusub ee aan yarayn

Kharash daawaynta kansarka sambabada unugyada cusub ee aan yarayn

Fahmidda Kharashyada Dawooyinka Cusub ee Kansarka Sambabada Unug Yaryar

Maqaalkani waxa uu bixiyaa dulmar guud oo ku saabsan kharashyada la xidhiidha kuwa cusub daawaynta cusub ee kansarka sanbabada unug yar-yar. Waxaan sahaminnaa xulashooyin daaweyn oo kala duwan, arrimaha saameynta ku leh qiimaha, iyo agabyada la heli karo si looga caawiyo bukaannada inay maraan caqabadaha maaliyadeed.

Noocyada Daawaynta Kansarka Sambabada Unug Yaryar Iyo Kharashkooda

Daawaynta La Beegsado

Daawaynta la beegsaday, sida EGFR inhibitors (sida Gefitinib iyo Erlotinib) iyo ALK inhibitors (sida Crizotinib iyo Alectinib), waxay diiradda saaraan isbeddellada hidde-sidaha gaarka ah ee keena koritaanka kansarka. Qiimaha ayaa si weyn u kala duwan iyadoo ku saleysan dawada gaarka ah, qiyaasta, iyo muddada daaweynta. Daawooyinkani waxay noqon karaan kuwo aad waxtar u leh, laakiin kharashkooda sarreeya ayaa caqabad weyn ku noqon kara bukaanno badan. Had iyo jeer kala hadal saamaynta kharashka dhakhtarkaaga kansarka oo sahamin barnaamijyada kaalmada maaliyadeed ee suurtogalka ah.

Immunotherapy

Daawooyinka Immunotherapy, sida isbaarada isbaarada (tusaale, Pembrolizumab, Nivolumab), waxay ka faa'idaystaan habka difaaca jidhka si uu ula dagaalamo kansarka. Daawayntani waxay wax ka beddeshay daryeelka kansarka sanbabada, laakiin badanaa waa qaali, oo leh kharashyo la mid ah ama ka badan daawaynta la beegsaday. Waxyaabaha ay ka midka yihiin daawada gaarka ah, qiyaasta, iyo jawaabta daaweynta waxay saameeyaan kharashka guud. Kooxdaada daryeelka caafimaadku waxay kaala hadli karaan kharashyada iman kara iyo barnaamijyada kaalmada ee la heli karo.

Chemotherapy

Kiimoterabiga ayaa weli ah aasaaska aasaasiga ah daawaynta cusub ee kansarka sanbabada unug yar-yar, inkastoo inta badan loo isticmaalo in lagu daro daaweynta kale. Kharashyadu aad bay u kala duwan yihiin waxayna ku xidhan tahay wakiilada kemotherabi ee gaarka ah ee la isticmaalo, habka qiyaasta, iyo muddada daawaynta. Iyadoo inta badan uu ka qaalisan yahay daawaynta la beegsaday ama immunotherapy ee ku salaysan daawaynta, kharashka isku-darka ah ee muddada daawaynta weli waa mid la taaban karo.

Daaweynta Shucaaca

Daaweynta shucaaca waxay isticmaashaa shucaac tamar sare leh si ay u burburiso unugyada kansarka. Kharashku wuxuu ku xiran yahay nooca daawaynta shucaaca ee la isticmaalo (shucaaca dibadda, brachytherapy, iwm.), tirada fadhiyada daawaynta, iyo kakanaanta qorshaha daaweynta. Habkan waxa loo isticmaali karaa kaligii ama marka lagu daro daawaynta kale.

Qalliin

Ka saarista qaliinka ee burada ayaa ah ikhtiyaar daawaynta bukaanada qaar ee qaba daawaynta cusub ee kansarka sanbabada unug yar-yar. Kharashku wuxuu ku xiran yahay inta uu le'eg yahay qaliinka (tusaale, lobectomy, pneumonectomy), kakanaanta habka, iyo kharashka isbitaalka. Daryeelka qalliinka kadib iyo dhibaatooyinka iman kara ayaa sidoo kale saameeya wadarta qiimaha.

Waxyaalaha Saamaynaya Qiimaha Daawaynta Kansarka Sambabada Unug Aan Yarayn

Qiimaha daawaynta cusub ee kansarka sanbabada unug yar-yar waxaa saameeya dhowr arrimood:

  • Nooca daawaynta: Sida kor looga hadlay, daawaynta kala duwan ayaa leh qiimo aad u kala duwan.
  • Qiyaasta iyo muddada daaweynta: Qiyaaso sare iyo daawaynta dheer waxay si dabiici ah u kordhiyaan kharashka guud.
  • Goobta daawaynta: Qiimaha ayaa si aad ah u kala duwan marka loo eego goobta juqraafiyeed iyo goobta daryeelka caafimaadka ee gaarka ah.
  • Caymiska caymiska: Siyaasadaha caymisku aad bay ugu kala duwan yihiin daboolka daawaynta kansarka. Fahamka siyaasaddaada gaarka ah waa muhiim.
  • Kharashaadka isbitaalka: Kharashaadka isbitaalka, sida qolka iyo guddiga, daryeelka kalkaalinta, iyo adeegyada kaabaya, waxay ku kordhiyaan kharashka guud.

U kuurgalka Caqabadaha Maaliyadeed ee Daaweynta Kansarka Sambabada

Qiimaha sare ee daaweynta kansarku wuxuu noqon karaa mid xad dhaaf ah. Nasiib wanaag, ilo kala duwan ayaa loo heli karaa si ay u caawiyaan bukaannada maaraynta kharashyadan:

  • Shirkadaha caymiska: La xidhiidh bixiyaha caymiskaaga si aad u fahanto caymiskaaga iyo faa'iidooyinkaaga.
  • Barnaamijyada kaalmada bukaanka (PAPs): Shirkado badan oo dawooyin ah ayaa bixiya PAPs si ay uga caawiyaan bukaanada inay awoodaan dawooyinkooda. Macluumaad dheeraad ah ka hubi barta internetka ee soo saaraha.
  • Ururada samafalka: Hay'ado dhowr ah ayaa gargaar dhaqaale siiya bukaannada kansarka iyo qoysaskooda. Ururka Kansarka Mareykanka iyo ururada la midka ah ayaa ah bar bilow wanaagsan.
  • Barnaamijyada dawladda: Baadh inaad u qalanto barnaamijyada kaalmada dawladda sida Medicaid ama Medicare.

Xusuusnow inaad si firfircoon ugala hadasho kharashka kooxdaada daryeelka caafimaadka. Waxay ku siin karaan hagitaan ku saabsan doorashooyinka daawaynta, barnaamijyada kaalmada maaliyadeed, iyo agabka si ay gacan uga geystaan ​​socodsiinta caqabadaha maaliyadeed ee daryeelka kansarka. Si aad u hesho daryeelka guud ee kansarka, tixgeli la-talinta Shandong Baofa Machadka Cilmi-baarista Kansarka.

Jadwalka Isbarbardhigga Qiimaha (Tusaale Sawir ah)

Nooca Daawaynta Qiyaasta Qiimaha Sannadka (USD)1
Daawaynta la beegsaday (tusaale, EGFR inhibitor) $150,000 - $250,000
Immunotherapy (tusaale, Checkpoint Inhibitor) $180,000 - $300,000
Chemotherapy (habka caadiga ah) $50,000 - $100,000

1Fiiro gaar ah: Kuwani waa tusaalooyin tusaaleyn ah oo kaliya kharashyada dhabta ahi aad ayey u kala duwanaan karaan iyadoo lagu salaynayo duruufaha gaarka ah iyo arrimaha kor lagu soo sheegay. Kala tasho bixiyaha xanaanada caafimaadkaaga iyo shirkadda caymiska si aad u hesho qiyaasta qiimaha saxda ah.

Afeef: Macluumaadkan waxaa loogu talagalay ujeeddooyin waxbarasho oo keliya mana aha in loo tixgeliyo talo caafimaad. Had iyo jeer kala tasho bixiyaha xanaanada caafimaadkaaga wixii welwel caafimaad ah ama ka hor intaadan qaadan wax go'aan ah oo la xiriira caafimaadkaaga ama daaweyntaada.

la xidhiidha alaabta

Alaabooyinka la xidhiidha

Iibinta ugu fiican alaabta

Alaabta iibka ugu fiican
Guriga
Kiisaska caadiga ah
Annaga
Nala Soo Xidhiidh

Fadlan fariin noogu dhaaf